FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3132348832> ?p ?o ?g. }

• W3132348832 abstract "Gemcitabine plus Capecitabine (Gem/Cape) is a frequently adopted second line chemotherapy for metastatic adrenocortical carcinoma (ACC), but only a minority of patients is destined to obtain a clinical benefit. The identification of baseline predictive factors of efficacy is relevant. We retrospectively analyzed clinical data from 50 consecutive patients with metastatic progressing ACC treated between 2011 and 2019. Patients received intravenous Gemcitabine and oral Capecitabine on a metronomic schedule. Previous mitotane therapy was maintained. Clinical benefit (partial response + stable disease) at 4 months was 30%, median progression-free survival (PFS) and disease-specific survival (DSS) from Gem/Cape start were 3 and 8 months, respectively. Among clinical variables evaluated before the start of Gem/Cape, presence of ECOG performance status ≥1 [HR 6.93 95% confidence interval (CI) 0.03-0.54, p.004] and neutrophil-to-lymphocyte ratio (NLR) ≥5 [HR 3.88, 95% (CI) 0.81-0.90, p.003] were independent indicators of poor PFS at multivariate analysis. Conversely, surgery of primary tumor, the presence of lung or lymph-node metastases, blood mitotane level, anemia, and the Advanced Lung cancer Inflammation index (ALI) failed to be independently associated. This study confirms that the Gem/Cape schedule is modestly active in heavily pretreated ACC patients (28% received at least two previous chemotherapy lines). NLR and performance status (PS) are easily available clinical parameters that are helpful to identify patients not likely to derive significant advantage from Gem/Cape chemotherapy." @default.
• W3132348832 created "2021-03-01" @default.
• W3132348832 creator A5003133890 @default.
• W3132348832 creator A5020684039 @default.
• W3132348832 creator A5029272729 @default.
• W3132348832 creator A5042603393 @default.
• W3132348832 creator A5048526224 @default.
• W3132348832 creator A5049277651 @default.
• W3132348832 creator A5050426287 @default.
• W3132348832 creator A5076272065 @default.
• W3132348832 creator A5078363267 @default.
• W3132348832 creator A5081591952 @default.
• W3132348832 creator A5086312742 @default.
• W3132348832 date "2021-02-24" @default.
• W3132348832 modified "2023-09-27" @default.
• W3132348832 title "Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy" @default.
• W3132348832 cites W1593584969 @default.
• W3132348832 cites W1818191552 @default.
• W3132348832 cites W1967352082 @default.
• W3132348832 cites W2000445173 @default.
• W3132348832 cites W2016982939 @default.
• W3132348832 cites W2033658212 @default.
• W3132348832 cites W2037754934 @default.
• W3132348832 cites W2069722452 @default.
• W3132348832 cites W2077637101 @default.
• W3132348832 cites W2093713748 @default.
• W3132348832 cites W2095699011 @default.
• W3132348832 cites W2096859456 @default.
• W3132348832 cites W2103205860 @default.
• W3132348832 cites W2107287100 @default.
• W3132348832 cites W2153294383 @default.
• W3132348832 cites W2169412307 @default.
• W3132348832 cites W2175623323 @default.
• W3132348832 cites W2725215134 @default.
• W3132348832 cites W2755902041 @default.
• W3132348832 cites W2784283849 @default.
• W3132348832 cites W2808884452 @default.
• W3132348832 cites W2883682970 @default.
• W3132348832 cites W2894827508 @default.
• W3132348832 cites W2901300101 @default.
• W3132348832 cites W2979766962 @default.
• W3132348832 cites W2981985630 @default.
• W3132348832 doi "https://doi.org/10.3389/fendo.2021.624102" @default.
• W3132348832 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7943871" @default.
• W3132348832 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33716976" @default.
• W3132348832 hasPublicationYear "2021" @default.
• W3132348832 type Work @default.
• W3132348832 sameAs 3132348832 @default.
• W3132348832 citedByCount "7" @default.
• W3132348832 countsByYear W31323488322021 @default.
• W3132348832 countsByYear W31323488322022 @default.
• W3132348832 countsByYear W31323488322023 @default.
• W3132348832 crossrefType "journal-article" @default.
• W3132348832 hasAuthorship W3132348832A5003133890 @default.
• W3132348832 hasAuthorship W3132348832A5020684039 @default.
• W3132348832 hasAuthorship W3132348832A5029272729 @default.
• W3132348832 hasAuthorship W3132348832A5042603393 @default.
• W3132348832 hasAuthorship W3132348832A5048526224 @default.
• W3132348832 hasAuthorship W3132348832A5049277651 @default.
• W3132348832 hasAuthorship W3132348832A5050426287 @default.
• W3132348832 hasAuthorship W3132348832A5076272065 @default.
• W3132348832 hasAuthorship W3132348832A5078363267 @default.
• W3132348832 hasAuthorship W3132348832A5081591952 @default.
• W3132348832 hasAuthorship W3132348832A5086312742 @default.
• W3132348832 hasBestOaLocation W31323488321 @default.
• W3132348832 hasConcept C121608353 @default.
• W3132348832 hasConcept C126322002 @default.
• W3132348832 hasConcept C143998085 @default.
• W3132348832 hasConcept C2776694085 @default.
• W3132348832 hasConcept C2776735609 @default.
• W3132348832 hasConcept C2776907518 @default.
• W3132348832 hasConcept C2777909004 @default.
• W3132348832 hasConcept C2780258809 @default.
• W3132348832 hasConcept C526805850 @default.
• W3132348832 hasConcept C71924100 @default.
• W3132348832 hasConceptScore W3132348832C121608353 @default.
• W3132348832 hasConceptScore W3132348832C126322002 @default.
• W3132348832 hasConceptScore W3132348832C143998085 @default.
• W3132348832 hasConceptScore W3132348832C2776694085 @default.
• W3132348832 hasConceptScore W3132348832C2776735609 @default.
• W3132348832 hasConceptScore W3132348832C2776907518 @default.
• W3132348832 hasConceptScore W3132348832C2777909004 @default.
• W3132348832 hasConceptScore W3132348832C2780258809 @default.
• W3132348832 hasConceptScore W3132348832C526805850 @default.
• W3132348832 hasConceptScore W3132348832C71924100 @default.
• W3132348832 hasLocation W31323488321 @default.
• W3132348832 hasLocation W31323488322 @default.
• W3132348832 hasLocation W31323488323 @default.
• W3132348832 hasOpenAccess W3132348832 @default.
• W3132348832 hasPrimaryLocation W31323488321 @default.
• W3132348832 hasRelatedWork W2074496248 @default.
• W3132348832 hasRelatedWork W2078009464 @default.
• W3132348832 hasRelatedWork W2139955290 @default.
• W3132348832 hasRelatedWork W2275049615 @default.
• W3132348832 hasRelatedWork W2382613782 @default.
• W3132348832 hasRelatedWork W2419408601 @default.
• W3132348832 hasRelatedWork W2914717791 @default.
• W3132348832 hasRelatedWork W3007914843 @default.
• W3132348832 hasRelatedWork W3031015708 @default.
• W3132348832 hasRelatedWork W3132348832 @default.

• next